APA Alıntı

Smith, M. A., Reynolds, P., Kang, M. H., Kolb, E. A., Gorlick, R., Carol, C. H., . . . Houghton, P. J. (2014). Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program. Clin Cancer Res.

Chicago Stili Alıntı

Smith, Malcolm A., et al. "Synergistic Activity of PARP Inhibition By Talazoparib (BMN 673) With Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program." Clin Cancer Res 2014.

MLA Alıntı

Smith, Malcolm A., et al. "Synergistic Activity of PARP Inhibition By Talazoparib (BMN 673) With Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program." Clin Cancer Res 2014.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..